Assessing country UHC performance relative to spending: a DEA investigation
Presented by the Health systems’ efficiency’ Special Interest Group (EFFSIG)
- the methodology used to assess how well countries performance (UHC) relative to levels of spending;
- the results from the analysis of 83 low and middle income countries.
Presentation and discussion
- “Motivation and approach to the efficiency analysis: why this study?” Matthew Jowett, PhD.
- “Good performance at low spending levels and vice versa: an overview of the results and key messages:” Gabriela Flores, PhD.
- Q&A: Moderated by Elina Dale, PhD, Health Financing Technical Officer, WHO Geneva.
Matthew Jowett, PhD. Senior Health Financing Specialist, Dept. Health Systems Governance & Financing, World Health Organization, Geneva, Switzerland.
Matthew is a Senior Health Financing Specialist with the World Health Organization based in Geneva. He works on a range of health financing policy issues in coordination with WHO Regional Offices; he has recently supported the development of health financing reforms in Sudan and Iran, as well as region-wide initiatives in the Eastern Mediterranean and South-East Asian regions. Matthew leads the teams for development of capacity building support to member states, including both face-to-face, e-learning, and blended capacity building activities. He spent six years in the WHO Regional Office for Europe, where he was closely involved in reforms in Moldova, Georgia, and Armenia. He was also part of a team advising Ministries of Health on responses to the recent financial crisis in Western Europe. Prior to joining WHO, Matthew spent seven years in India and the Philippines working as a health financing policy specialist, and prior to that worked in Africa before taking a post as a researcher at the Centre for Health Economics, University of York, UK. His Ph.D. thesis analysed early attempts in Vietnam to extend the Vietnamese National Health Insurance programme to workers not in salaried employment.
Gabriela Flores, PhD. Health Economist, Economic Analysis and Evaluation (EAE), Health Systems and Innovation, World Health Organization, Geneva, Switzerland.
Gabriela is an expert with 15 years’ experience in the field of analytical assessment of financial protection and financial risk protection, econometric analysis of related data, and health financing strategies linked to moving closer to universal health coverage. She joined the World Health Organization in January 2015 to take the main responsibility of the monitoring of financial protection at global levels and support monitoring efforts in the WHO regions of the Americas, Europe and South-East Asia. She holds PhD in Statistics and Econometrics from the University of Geneva. She has published in Health Economics, Journal of Health Economics and the Lancet Global Health among others.